Brynn T Kvinlaug, BSc, MSc^1*, Wai-In Chan, PhD^1*, Lars Bullinger, MD^2*, Christopher Sears^3*, Donna Paul^1*, Rachel Okabe, BSc^4*, Benjamin H Lee, MD, PhD^4*, Inusha De Silva, PhD^1*, Scott Armstrong, MD, PhD^3*, Hartmut Dohner, MD^2*, D. Gary Gilliland⁵ and Brian JP Huntly, MD, PhD^1*

¹Hematology, University of Cambridge, Cambridge, United Kingdom
²Department of Internal Medicine III, University of Ulm, Ulm, Germany
³Hematology, Childrens Hospital, Boston, MA
⁴Harvard Medical School, Brigham & Women's Hospital, Boston, MA
⁵Brigham and Women's Hospital, Boston, MA

Aniruddha Deshpande^1*, Hendrik Reuter^2*, Medhanie Mulaw^1*, Monica Cusan^1*, Wolfgang Hiddemann¹, Stefan Bohlander^1*, Michaela Feuring-Buske^1* and Christian Buske¹

¹Helmholtz Centre, Munich, Munich, Germany
²Division of Molecular Genetics, German Cancer Research Center, Heidelberg, Germany

Monica Cusan^1*, Aniruddha Deshpande^1*, Vijay Rawat^1*, Wolfgang Hiddemann^1*, Leticia Quintanilla-Martinez, MD^2*, R. Keith Humphries, MD, PhD³, Christian Buske, MD¹ and Michaela Feuring-Buske^1*

¹Helmholtz Centre, Munich, Munich, Germany
²Pathology, University Hospital Tuebingen, Eberhard-Karls-University, Tuebingen, Germany
³Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada

Thomas Mercher, Ph.D^1*, Glen D. Raffel, MD, PhD², Sandra A Moore^3*, Melanie G Cornejo^4*, Dominique Baudry-Bluteau, Ph.D^5*, Nicolas Cagnard^6*, Jonathan Jesneck^7*, Yana Pikman^3*, Dana E. Cullen^8*, Ifor Williams^9*, Koichi Akashi, MD, PhD¹⁰, Hirokazu Shigematsu^10*, Jean-Pierre Bourquin, MD, PhD^11*, Marco Giovannini, MD, PhD^12*, William Vainchenker⁵, Ross L Levine, MD¹³, Benjamin H. Lee, MD, PhD^14*, Olivier Bernard^15* and D. Gary Gilliland¹⁴

¹Brigham and Women's Hospital, 1 Blackfan circle 02115 Boston USA and INSERM EMI0210, Universite Paris V-Descartes, Paris, France
²Beth Israel Deaconess Med. Ctr., Boston, MA
³Department of Medicine, Brigham and Women's Hospital, Boston, MA
⁴Harvard Medical School, Boston, MA
⁵INSERM U790, Villejuif, France
⁶INSERM EMI0210, Paris, France
⁷Dana Farber Cancer Institute, Boston, MA
⁸Department of Medicine, Division of Hematology, Brigham and Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School, Boston, MA
⁹Hematology & Oncology, Emory University, Atlanta, GA
¹⁰Dana-Farber Cancer Inst., Boston, MA
¹¹Paediatric Haematology/Oncology, University of Zurich, Zurich, Switzerland
¹²INSERM U434, Paris, France
¹³Memorial Sloan-Kettering Cancer Center, New York, NY
¹⁴Brigham and Women's Hospital, Boston, MA
¹⁵Hôpital Necker-Enfants Malades, Laboratoire d'Hématologie, Paris, France

Safak Yalcin^1*, Sathish Kumar Mungamuri^1*, Dragan Marinkovic^1*, Xin Zhang^1*, Wei Tong, PhD², Dana Cullen^1* and Saghi Ghaffari, MD, PhD³

¹Mount Sinai School of Medicine, New York, NY
²CHOP, Philadelphia, PA
³Department of Molecular, Cell & Developmental Biology, Department of Gene and Cell Medicine, New York, NY

Eric R Lechman, MS, PhD^1*, Hidefumi Hiramatsu, MD, PhD², Bernhard Gentner, MD^3*, Kristin Hope, PhD^1*, Katsuto Takenaka, MD⁴, Kolja Eppert, PhD^1*, Mark D. Minden, MD, PhD⁵, Luigi Naldini^6* and John E. Dick, PhD⁷

¹Cell and Molecular Biology, University Health Network, Toronto, ON, Canada
²Toronto Med. Discovery Tower 8-301, Toronto, ON, Canada
³HSR-TIGET, Milan, Italy
⁴Dept. of Internal Medicine I, Kyushu Univ. Med. School, Fukuoka, Japan
⁵Princess Margaret Hospital, Toronto, ON, Canada
⁶Telethon Institute for Gene Therapy, San Raffaele Scientific Institute, Milan, Italy
⁷University Health Network, Toronto, ON, Canada